Genetic Mediation of Obesity-Breast Cancer Link via Circulating Biomarkers

Overview

This study used a two-stage Mendelian randomization approach to investigate the causal mediating roles of eight circulating biomarkers in the relationship between body mass index (BMI) and breast cancer risk. The analysis leveraged large-scale genome-wide association study (GWAS) data from European populations, identifying key biomarkers potentially mediating the obesity-breast cancer association.

Background

Breast cancer is the most commonly diagnosed cancer among females worldwide, with obesity recognized as a complex risk factor. While observational studies have suggested a positive association between adult BMI and breast cancer risk, especially postmenopausal estrogen receptor-positive types, genetic analyses have paradoxically shown an inverse relationship. Circulating biomarkers related to insulin signaling and inflammation may mediate this relationship, but prior observational studies have been limited by simultaneous measurement timing, small sample sizes, and short-term biomarker assessments. Mendelian randomization (MR) offers a method to infer causality by using genetic variants as instrumental variables, providing insights into lifetime biomarker effects on breast cancer risk.

Data Highlights

Key Findings

• Genetically predicted BMI showed complex associations with breast cancer risk, challenging prior observational findings.
• Eight circulating biomarkers were evaluated as potential mediators, focusing on insulin/IGF axis and inflammatory pathways.
• Instrumental variables were selected based on genome-wide significance and independence, excluding SNPs associated with breast cancer to reduce bias.
• Relaxed significance thresholds were applied for biomarkers with smaller GWAS sample sizes to ensure adequate instrument selection.
• Mendelian randomization mediation analysis enables causal inference of biomarker mediation in the BMI-breast cancer relationship, overcoming limitations of observational studies.

Clinical Implications

Understanding the causal mediating roles of specific circulating biomarkers can refine risk stratification for breast cancer in obese individuals and guide targeted prevention strategies. The use of genetic instruments to infer lifetime biomarker effects supports the development of interventions aimed at modulating these pathways. Clinicians should consider the complex biological interplay between obesity, metabolic factors, and breast cancer risk when evaluating patient risk profiles.

Conclusion

This Mendelian randomization study provides novel insights into the biological pathways linking obesity and breast cancer risk through circulating biomarkers. These findings highlight the importance of genetic mediation analyses in elucidating complex disease mechanisms and may inform future preventive and therapeutic approaches.

References

1. Breast Cancer Association Consortium 2020 -- GWAS of Breast Cancer Risk
2. GIANT Consortium & UK Biobank 2019 -- GWAS of BMI
3. Dashti et al. 2018/2019 -- Insulin and Estradiol Mediation in Breast Cancer
4. STROBE-MR Guidelines 2020 -- Reporting Mendelian Randomization Studies